Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NanoSHIFT LLC
With
United States Department of Defense
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be 18 years of age or older
Women of childbearing potential must have a negative urine pregnancy test at screening and at baseline
Agree to use a double-barrier method of contraception during their participation in this study
* condoms (with spermicide) and hormonal contraceptives OR
* condoms (with spermicide) and intrauterine device OR
* intrauterine device and hormonal contraceptives OR
Abstains from sexual intercourse during their participation in this study
Is with a same-sex partner and does not participate in bisexual activities where there is a risk of becoming pregnant
Have a full-thickness trauma wound that is between 1.2cm2 and 24cm2 at initial screening
Be able to apply study drug to their wound, or have a reliable and capable caregiver do it
Subjects will have adequate blood flow to the wound as defined by transcutaneous oxygen tension (TcpO2) of \>30mmHg recorded over intact epidermis at the wound margin.
You may not be if
Less than 18 years of age
Pregnant or lactating woman or a female of childbearing potential who is not practicing acceptable form of birth control.
Allergic to tetracycline, minocycline, demeclocycline, or any other known tetracycline derivative
Tested positive for a doxycycline-resistant infection
Have undergone treatment with systemic corticosteroid or immunosuppressive therapy in the past 2 months
Currently undergoing dialysis for renal failure
Have participated in another clinical research trial within the last 30 days
Subject has wounds resulting from any cause other than trauma (diabetes, electrical burn, arterial insufficiency, chemical or radiation insult)
Active or previous (within 60 days prior to the study screening visit) chemotherapy
Active or previous (within 60 days prior to the study screening visit) radiation to the affected wound area to be treated by investigational drug or placebo
Physical or mental disability or geographical concerns (residence not within reasonable travel distance) that would hamper compliance with required study visits
The Investigator believes that the subject will be unwilling or unable to comply with study protocol requirements, including the shock wave treatment procedure, standard-of-care self-care requirements, and all study-related follow up visit requirements.
History of sickle cell anemia
History of infection with Human Immunodeficiency Virus
History of other immunodeficiency disorders
Severe anemia - Hgb \< 7 g/dl (males) or \< 6.5 (females)